ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 285,86
-0,60%
Dow Jones
39 142,23
-1,33%
DAX
21 205,86
-0,52%
Brent Oil
67,075
0,00%
Bitcoin
85 040,26
0,66%
Registration Strip Icon for charts Inscrivez-vous pour des graphiques en temps réel, des outils d'analyse et des prix.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ

  6. Petros Pharmaceuticals Inc (PTPI) Cours

Petros Pharmaceuticals Inc

Petros Pharmaceuticals Inc (PTPI)

NASDAQ
0,041
0,0009
(2,24%)
Fermé 19 Avril 10:00PM
Retardé de 15 minutes
0,042
0,001
(2,44%)
Après les heures de négociation: 1:58AM
Retardé de 15 minutes

Donnez du pouvoir à votre portefeuille : discussions en temps réel et idées de trading exploitables.

Premium

Statistiques et détails clés

Dernier
0,042
Prix Achat
0,0404
Prix Vente
0,042
Volume échangé
1 440 743
0,0402 Fourchette du Jour 0,043
0,04 Plage de 52 semaines 0,7664
Cap du marché
2,248M
Clôture Veille
0,0401
Ouverture
0,0406
Dernière Transaction
1000
@
0.042
(formt)
Dernière heure de transaction
Volume financier
US$ 58 890
VWAP
0,040875
Volume moyen (3 m)
37 892 731
Actions en circulation
53 519 045
Rendement du Dividende
-
Ratio Cours sur Bénéfices
-0,15
Bénéfice par action (BPA)
-0,26
Chiffre d'affairess
5,82M
Bénéfice net
-13,81M

À propos de Petros Pharmaceuticals Inc

Petros Pharmaceuticals Inc is a men's health pharmaceutical company. It focuses on identifying, developing, acquiring, and commercializing innovative therapeutics for men's health issues including erectile dysfunction, peyronie's disease, hormone health and substance use disorders. The company's ope... Petros Pharmaceuticals Inc is a men's health pharmaceutical company. It focuses on identifying, developing, acquiring, and commercializing innovative therapeutics for men's health issues including erectile dysfunction, peyronie's disease, hormone health and substance use disorders. The company's operating segment includes Prescription Medications and Medical Devices. It generates maximum revenue from the Prescription Medications segment. The Prescription Medications segment consists primarily of operations related to Stendra, which is sold generally in the United States, and H100 for the treatment of Peyronie's disease. Show more

Secteur
Pharmaceutical Preparations
Industrie
Pharmaceutical Preparations
Site Web
www.petrospharma.com
Siège social
Wilmington, Delaware, USA
Fondé
-
Petros Pharmaceuticals Inc est coté dans le secteur Pharmaceutical Preparations de la NASDAQ avec le ticker PTPI. Le dernier cours de clôture d'Petros Pharmaceuticals était de US$0,04. Au cours de la dernière année, les actions de Petros Pharmaceuticals ont été négociées dans une fourchette de prix de US$ 0,04 à US$ 0,7664.

Petros Pharmaceuticals compte actuellement 53 519 045 actions en circulation. La capitalisation boursière d'Petros Pharmaceuticals est de US$2,15 million. Petros Pharmaceuticals a un ratio cours/bénéfice (ratio PE) de -0.15.

PTPI Dernières nouvelles

Plus de nouvelles

Form 8-K - Current report
Edgar (US Regulatory)
09 Avril 2025
PTPI (2,24%)

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Edgar (US Regulatory)
31 Mars 2025
PTPI (2,24%)

Form DEF 14A - Other definitive proxy statements
Edgar (US Regulatory)
18 Mars 2025
PTPI (2,24%)

Form PRER14A - Preliminary Proxy Soliciting materials
Edgar (US Regulatory)
14 Mars 2025
PTPI (2,24%)

Form PRE 14A - Other preliminary proxy statements
Edgar (US Regulatory)
07 Mars 2025
PTPI (2,24%)

Form 4 - Statement of changes in beneficial ownership of securities
Edgar (US Regulatory)
21 Février 2025
PTPI (2,24%)

Form 4 - Statement of changes in beneficial ownership of securities
Edgar (US Regulatory)
21 Février 2025
PTPI (2,24%)

Form 8-K - Current report
Edgar (US Regulatory)
21 Février 2025
PTPI (2,24%)

Form 424B4 - Prospectus [Rule 424(b)(4)]
Edgar (US Regulatory)
19 Février 2025
PTPI (2,24%)

Form EFFECT - Notice of Effectiveness
Edgar (US Regulatory)
18 Février 2025
PTPI (2,24%)
PériodeVariationVariation %Ouver.HautBasMoyenne Vol. Quot.VWAP
1-0.008-160.050.05080.0429382910.04656519CS
4-0.034-44.73684210530.0760.230.04914009410.12791369CS
12-0.294-87.50.3360.650.04378927310.13402421CS
26-0.301-87.75510204080.3430.650.04188751740.14986275CS
52-0.638-93.82352941180.680.76640.0494275580.15458635CS
156-11.858-99.647058823511.928.80.0437022591.09868746CS
260-17.958-99.76666666671859.5990.04364468110.51914355CS

PTPI - Frequently Asked Questions (FAQ)

What is the current Petros Pharmaceuticals share price?
The current share price of Petros Pharmaceuticals is US$ 0,042
How many Petros Pharmaceuticals shares are in issue?
Petros Pharmaceuticals has 53 519 045 shares in issue
What is the market cap of Petros Pharmaceuticals?
The market capitalisation of Petros Pharmaceuticals is USD 2,15M
What is the 1 year trading range for Petros Pharmaceuticals share price?
Petros Pharmaceuticals has traded in the range of US$ 0,04 to US$ 0,7664 during the past year
What is the PE ratio of Petros Pharmaceuticals?
The price to earnings ratio of Petros Pharmaceuticals is -0,15
What is the cash to sales ratio of Petros Pharmaceuticals?
The cash to sales ratio of Petros Pharmaceuticals is 0,37
What is the reporting currency for Petros Pharmaceuticals?
Petros Pharmaceuticals reports financial results in USD
What is the latest annual turnover for Petros Pharmaceuticals?
The latest annual turnover of Petros Pharmaceuticals is USD 5,82M
What is the latest annual profit for Petros Pharmaceuticals?
The latest annual profit of Petros Pharmaceuticals is USD -13,81M
What is the registered address of Petros Pharmaceuticals?
The registered address for Petros Pharmaceuticals is CORPORATION TRUST CENTER, 1209 ORANGE STREET, WILMINGTON, DELAWARE, 19801
What is the Petros Pharmaceuticals website address?
The website address for Petros Pharmaceuticals is www.petrospharma.com
Which industry sector does Petros Pharmaceuticals operate in?
Petros Pharmaceuticals operates in the PHARMACEUTICAL PREPARATIONS sector

Moteurs

Voir tout
  • Volume
  • % Gagnants
  • % Perdants
SymbolePrixVol.
MSGMMotorsport Games Inc
US$ 2,69
(140,18%)
37M
SXTCChina SXT Pharmaceuticals Inc
US$ 2,11
(113,37%)
51,73M
ADGMAdagio Medical Holdings Inc
US$ 1,68
(81,98%)
115,48M
PNBKPatriot National Bancorp Inc
US$ 3,28
(73,54%)
1,57M
RTCBaijiayun Group Ltd
US$ 0,3601
(67,49%)
187,02M
LXEHLixiang Education Holding Company Ltd
US$ 8,25
(-64,11%)
1,55M
CLIKClick Holdings Ltd
US$ 0,355
(-48,18%)
13,52M
IOTRiOThree Ltd
US$ 1,1409
(-38,33%)
3,93M
FMTOFemto Technologies Inc
US$ 0,0191
(-35,47%)
198,4M
SISIShineco Inc
US$ 0,5809
(-35,07%)
824,91k
DMNDamon Inc
US$ 0,0034
(9,68%)
409,39M
STSSSharps Technology Inc
US$ 0,03195
(20,57%)
391,8M
SUNESUNation Energy Inc
US$ 0,0176
(-10,20%)
349,4M
NVDANVIDIA Corporation
US$ 101,49
(-2,87%)
292,48M
HTZHertz Global Holdings Inc
US$ 8,205
(43,70%)
266,91M

Forums

Afficher les forums
Aucune Discussion Trouvée
Ajouter une Discussion

Dernières Valeurs Consultées

NASDAQ
PTPI
Petros Pharmaceuticals
Delayed Upgrade Clock
ADVFN Logo
France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2025 ADVFN PLC - Tous droits réservés

Supprimer les publicités

Inscrivez-vous pour une expérience sans publicité

Aucune publicité

Essayez maintenant

Conserver les annonces